Cogent Biosciences, Inc.

COGT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $28.3M
Accounts Receivable $830.0K
Inventory —
Total Current Assets $42.4M
Property, Plant & Equipment $4.1M
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $49.1M
Liabilities
Accounts Payable $1.3M
Total Current Liabilities $11.2M
Long-Term Debt —
Total Liabilities $20.8M
Stockholders' Equity
Retained Earnings $-51.3M
Total Stockholders' Equity $-48.8M
← Newer Page 2 of 2 Older →